Clinical Trial: Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma

U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07272278) titled 'Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma' on Nov. 26.

Brief Summary: To investigate the impact of the combination of ICS/LABA and Liqin Zhike Formula on the clinical efficacy and prognostic outcomes of cough variant asthma.

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: ICS+LABA

CVA patients receive ICS/LABA treatment

DRUG: Chinese Medicine Formula

CVA patients receive ICS/LABA + Liqin Zhike Formula treatment

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sec...